Moderate Levels of N-Terminal Pro-B-Type Natriuretic Peptide is Associated with Increased Risks of Total and Ischemic Strokes among Japanese: The Circulatory Risk in Communities Study.


Journal

Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298

Informations de publication

Date de publication:
01 Aug 2020
Historique:
pubmed: 15 1 2020
medline: 5 6 2021
entrez: 15 1 2020
Statut: ppublish

Résumé

N-terminal pro-B-type natriuretic peptide (NT-proBNP), frequently used as a biochemical marker for detecting and monitoring heart failure, is also a risk marker for development of coronary heart disease and total stroke. However, studies that explore subtypes of ischemic stroke with regard to NT-proBNP are scarce. Here, we examined NT-proBNP and its impact upon subtypes of ischemic stroke (lacunar stroke, large-artery occlusive stroke and embolic stroke) among Japanese. We measured NT-proBNP and categorized 4,393 participants of the Circulatory Risk in Communities Study into four groups (<55, 55-124, 125-399, and ≥ 400 pg/ml). We used a multivariable Cox proportional hazards model to examine association with risks of stroke and subtypes. During 4.7 years of follow-up, we identified 50 strokes, including 35 ischemic (15 lacunar, 6 largeartery occlusive, 10 embolic strokes) and 14 hemorrhagic strokes. NT-proBNP was associated with stroke risk: the multivariable hazard ratio of total strokes was 7.29 (2.82-18.9) for the highest and 2.78 (1.25-6.16) for the second highest NT-proBNP groups compared with the lowest group. The respective hazard ratios for the highest NT-proBNP group were 9.37 (3.14-28.0) for ischemic stroke and 6.81 (1.11-41.7) for lacunar stroke. Further adjustment for atrial fibrillation did not attenuate these associations. The associations were similarly observed for large-artery occlusive and embolic strokes. We found that even moderate serum levels of NT-proBNP were associated with the risk of total and ischemic strokes among Japanese whose NT-proBNP levels were relatively low compared with Westerners.

Identifiants

pubmed: 31932552
doi: 10.5551/jat.52241
pmc: PMC7458784
doi:

Substances chimiques

Biomarkers 0
Peptide Fragments 0
pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

751-760

Commentaires et corrections

Type : CommentIn

Références

Hypertension. 2010 Mar;55(3):785-91
pubmed: 20083731
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Stroke. 2012 Feb;43(2):441-5
pubmed: 22116811
Int J Cardiol. 2016 Nov 15;223:74-81
pubmed: 27541645
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
J Card Fail. 2005 Jun;11(5 Suppl):S81-3
pubmed: 15948107
Ann Epidemiol. 2000 Feb;10(2):81-7
pubmed: 10691061
Ultrasound Med Biol. 2002 Oct;28(10):1239-43
pubmed: 12467849
Circ J. 2018 Jul 25;82(8):2055-2062
pubmed: 29887544
Circulation. 2010 Jan 19;121(2):200-7
pubmed: 20048208
Eur J Heart Fail. 2019 Apr;21(4):449-459
pubmed: 30656792
Stroke. 2019 Mar;50(3):610-617
pubmed: 30786848
JAMA. 2005 Apr 6;293(13):1609-16
pubmed: 15811980
J Am Heart Assoc. 2019 Jan 22;8(2):e010107
pubmed: 30651032
Stroke. 2014 Jun;45(6):1646-50
pubmed: 24757103
Circulation. 2012 Apr 3;125(13):1605-16
pubmed: 22374183
Stroke. 2013 Apr;44(4):961-7
pubmed: 23471272
J Neurol Sci. 2017 Dec 15;383:5-10
pubmed: 29246621
Clin Res Cardiol. 2014 Jun;103(6):477-85
pubmed: 24488175
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334
Eur J Heart Fail. 2004 Mar 15;6(3):295-300
pubmed: 14987579
Heart Vessels. 2019 Jul;34(7):1178-1186
pubmed: 30656414
N Engl J Med. 2004 Feb 12;350(7):655-63
pubmed: 14960742
EPMA J. 2011 Mar;2(1):49-57
pubmed: 23199126
Circulation. 2009 Dec 1;120(22):2177-87
pubmed: 19917883
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2997-3003
pubmed: 21921261
Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1698-702
pubmed: 27339461
J Epidemiol. 2019 Mar 5;29(3):83-91
pubmed: 30584233
Stroke. 2010 Jul;41(7):1349-55
pubmed: 20522816

Auteurs

Kenji Ebihara (K)

Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba.

Kazumasa Yamagishi (K)

Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba.
Osaka Center for Cancer and Cardiovascular Disease Prevention.
Ibaraki Western Medical Center.

Mitsumasa Umesawa (M)

Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba.
Osaka Center for Cancer and Cardiovascular Disease Prevention.
Department of Public Health, Dokkyo Medical University School of Medicine.

Isao Muraki (I)

Osaka Center for Cancer and Cardiovascular Disease Prevention.
Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.

Renzhe Cui (R)

Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.

Hironori Imano (H)

Osaka Center for Cancer and Cardiovascular Disease Prevention.
Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.

Yasuhiko Kubota (Y)

Osaka Center for Cancer and Cardiovascular Disease Prevention.

Mina Hayama-Terada (M)

Osaka Center for Cancer and Cardiovascular Disease Prevention.
Yao Public Health Center, Yao City Office.

Yuji Shimizu (Y)

Osaka Center for Cancer and Cardiovascular Disease Prevention.

Tetsuya Ohira (T)

Department of Epidemiology, Fukushima Medical University School of Medicine.

Tomoko Sankai (T)

Department of Public Health and Nursing, Faculty of Medicine, University of Tsukuba.

Takeo Okada (T)

Osaka Center for Cancer and Cardiovascular Disease Prevention.

Akihiko Kitamura (A)

Osaka Center for Cancer and Cardiovascular Disease Prevention.
Research Team for Social Participation and Community Health, Tokyo Metropolitan Institute of Gerontology.

Masahiko Kiyama (M)

Osaka Center for Cancer and Cardiovascular Disease Prevention.

Hiroyasu Iso (H)

Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba.
Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH